Analysis of risk factors for the development of liver disease associated with cystic fibrosis
- 1 March 1994
- journal article
- Published by Elsevier in The Journal of Pediatrics
- Vol. 124 (3), 393-399
- https://doi.org/10.1016/s0022-3476(94)70361-2
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- The changing epidemiology of cystic fibrosisThe Journal of Pediatrics, 1993
- Effects of ursodeoxycholic acid on liver function in patients with cystic fibrosis and chronic cholestasisThe Journal of Pediatrics, 1992
- Genotype analysis for ΔF508, G551D and R553X mutations in children and young adults with cystic fibrosis with and without chronic liver diseaseHepatology, 1992
- Cystic fibrosis: Beyond the gene to therapyThe Journal of Pediatrics, 1992
- Effects of ursodeoxycholic acid therapy for liver disease associated with cystic fibrosisThe Journal of Pediatrics, 1990
- PCR test for cystic fibrosis deletionNature, 1990
- Clinical and genetic comparisons of patients with cystic fibrosis, with or without meconium ileusThe Journal of Pediatrics, 1989
- Liver Disease and Common-Bile-Duct Stenosis in Cystic FibrosisNew England Journal of Medicine, 1988
- Hepatobiliary Disease in Cystic FibrosisJournal of Pediatric Gastroenterology and Nutrition, 1982
- The management of portal hypertension in cystic fibrosisJournal of Pediatric Surgery, 1977